DiaMedica Therapeutics, Inc. Annual report pursuant to Section 13 and 15(d)

Note 8 - Accounts Payable and Accrued Liabilities

12 Months Ended

Dec. 31, 2019

8.	Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following (in thousands):

	December 31, 201 9		December 31, 2018
Trade and other payables	$	182	$	483
Accrued clinical study costs		433		292
Accrued compensation		419		417
Accrued research and other professional fees		172		65
Accrued taxes and other liabilities		52		34
Total accrued liabilities	$	1,258	$	1,291